Doctours, a Los Angeles-based online platform for booking trips and treatments for medical and dental care around the world, is expanding its services to 35 countries.

Founded by serial travel entrepreneur Katelyn O’Shaughnessy, whose last company TripScope was acquired by Travefy, Doctours aims to connect patients with doctors to receive access to quality, affordable healthcare around the world.

The cost of care in the U.S. continues to climb, leading patients with few options but to travel to the best facilities offering the lowest cost care. Some companies that provide insurance benefits to their employees, like Walmart, are opting to pay for better care upfront by transporting their workers to facilities to receive appropriate care, rather than pay later for shoddy treatment.

Doctours sort of expands that thesis in an international context.

“When it comes to medical and dental treatment, there is no longer any reason to limit ourselves based on where we live,” said O’Shaughnessy, in a statement. “There is an increasingly advantageous global marketplace available with highly trained practitioners offering quality healthcare solutions at affordable prices and, although medical and dental tourism is a safe and cost-efficient solution, the current market is extremely fragmented and challenging to navigate. Doctours eliminates this fragmentation and allows anyone to easily and affordably access international medical and dental treatments and procedures.”

The company, which is backed by investors, including the former CEO of Expedia, Erik Blachford; Texas billionaire and CEO of multi-strategy holding company Cathexis, William Harrison; and Charles Cogliando of Mosaic Advisors, offers more than 330 different medical and dental procedures and has a global service area that includes Mexico, Colombia, the Caribbean, Thailand, Dubai, Brazil, Germany and Costa Rica.

Currently working out of Quake Capital’s Austin incubator, the company helps patients search for and compare the cost of procedures, connect with doctors and book everything from in vitro fertilization to stem cell therapy, cosmetic and reparative plastic surgery, weight loss surgery, dental work and Lasik.

Once the procedure is booked, Doctours puts together itineraries that provide different options for flights and hotels based on the needs of the patient, the company said.

The company also offers specialized medical tourism insurance to all of its customers, according to O’Shaughnessy. And the company vets its doctors by ensuring that they are Joint Commission International accredited physicians. Roughly 70% of the company’s doctors were trained at universities and medical schools in Europe or the U.S., O’Shaughnessy wrote in an email.

Doctours is certainly entering a lucrative market. Medical and dental tourism is a $439 billion global market growing at a rate of 25% per year, according to data provided by Doctours. In 2018 alone, 14 million patients traveled abroad to seek healthcare, according to the company.